Trademark: 97611312
Status Date
Tuesday, May 21, 2024
Registration Number
7392963
Registration Date
Tuesday, May 21, 2024
Filing Date
Wednesday, September 28, 2022
Published for Opposition
Tuesday, January 23, 2024
5 Preparations for the relief of conditions caused by atopy for oral delivery and topical administration, namely, pharmaceutical preparations for developing tolerance to allergens; Preparations for the relief of allergies customized for a patient based on results from the patient's allergy tests, namely, pharmaceutical preparations for developing tolerance to allergens; Preparations for the relief of allergies customized for a patient based on results from the patient's at-home allergy tests, namely, pharmaceutical preparations for developing tolerance to allergens; Patient-customized preparations for the relief of allergies, namely, pharmaceutical preparations for developing tolerance to allergens; Patient-customized preparations for the relief of conditions caused by atopy for oral delivery and topical administration, namely, pharmaceutical preparations for developing tolerance to allergens; At-home allergy test kits comprised of medical diagnostic test patches for detecting allergen-specific immunoglobulin E (IgE) antibodies in blood samples in order to determine allergic reactions; Direct-to-consumer allergy test kits comprised of medical diagnostic test patches for detecting allergen-specific immunoglobulin E (IgE) antibodies in blood samples in order to determine allergic reactions for the purpose of obtaining information for customized preparations for the relief of allergies; Direct-to-consumer allergy test kits comprised of medical diagnostic test patches for detecting allergen-specific immunoglobulin E (IgE) antibodies in blood samples in order to determine allergic reactions for the purpose of obtaining information for customized pharmaceutical preparations for developing tolerance to allergens
44 Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient administered allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's at home allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, for determining a treatment plan with prescription allergy medication in a formulation customized according to results of a patient's direct-to-consumer allergy test; Telemedicine services and telemedicine treatment services for treatment of conditions caused by atopy, namely, information regarding a treatment plan with customized pharmaceutical preparations for developing tolerance to allergens
Color is not claimed as a feature of the mark.
Oct 1, 2022
New Application Entered
Oct 16, 2022
New Application Office Supplied Data Entered
Oct 18, 2022
Notice Of Design Search Code E-Mailed
Jul 12, 2023
Assigned To Examiner
Oct 12, 2023
Teas Response To Office Action Received
Jul 13, 2023
Non-Final Action Written
Jul 13, 2023
Non-Final Action E-Mailed
Jul 13, 2023
Notification Of Non-Final Action E-Mailed
Oct 12, 2023
Correspondence Received In Law Office
Oct 13, 2023
Teas/Email Correspondence Entered
Oct 16, 2023
Final Refusal Written
Oct 16, 2023
Final Refusal E-Mailed
Oct 16, 2023
Notification Of Final Refusal Emailed
Dec 7, 2023
Teas Request For Reconsideration Received
Dec 7, 2023
Correspondence Received In Law Office
Dec 8, 2023
Teas/Email Correspondence Entered
Dec 12, 2023
Teas Request For Reconsideration Received
Dec 12, 2023
Correspondence Received In Law Office
Dec 12, 2023
Action Req For Recon Denied No Appeal Filed Counted Not Mailed
Dec 12, 2023
Action For Req For Recon Denied No Appeal Filed E-Mailed
Dec 12, 2023
Notification For Req For Recon Denied No Appeal Filed
Dec 13, 2023
Teas/Email Correspondence Entered
Dec 18, 2023
Approved For Pub - Principal Register
Jan 23, 2024
Published For Opposition
Jan 3, 2024
Notification Of Notice Of Publication E-Mailed
Jan 23, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 19, 2024
Noa E-Mailed - Sou Required From Applicant
Mar 22, 2024
Use Amendment Filed
Apr 12, 2024
Case Assigned To Intent To Use Paralegal
Apr 13, 2024
Statement Of Use Processing Complete
Apr 17, 2024
Allowed Principal Register - Sou Accepted
Apr 18, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
May 21, 2024
Registered-Principal Register
May 21, 2024
Notice Of Registration Confirmation Emailed
Mar 22, 2024
Teas Statement Of Use Received
Trademark Alertz updated from USPTO on 2030-01-24
